Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (421-430 of 604) with videos related to

Pageof 61
Sort By:
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Methodsx|June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCsPugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECTMarcus M Unger, Jens C Möller, Karin Stiasny-Kolster, et al.
Human Gene Therapy. Clinical Development|March 25, 2017
Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck CancerClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Journal of Parkinson'S Disease|August 18, 2020
Gastric Motility in Parkinson's Disease is Altered Depending on the Digestive Phase and Does Not Correlate with Patient-Reported Motor FluctuationsLaura Ruck, Marcus M Unger, Jörg Spiegel, et al.
NPJ Parkinson'S Disease|December 10, 2019
Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiotaSeverin Weis, Andreas Schwiertz, Marcus M Unger, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill PatientsM G Vossen, D Knafl, M Haidinger, et al.
JNCI Cancer Spectrum|July 25, 2020
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJoseph M Unger, Dawn L Hershman, Raymond U Osarogiagbon, et al.
American Journal of Veterinary Research|July 25, 2017
Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of catsClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2013
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213S H Bernstein, E Epner, J M Unger, et al.
Pageof 61

Showing results (421-430 of 604) with videos related to

Sort By:
Pageof 61
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Methodsx|June 3, 2026
Flow cytometry method to identify arginase-1 expressing MDSCsPugazhendhi Srinivasan, Misty Bechtel, Dorota Wyczechowska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECTMarcus M Unger, Jens C Möller, Karin Stiasny-Kolster, et al.
Human Gene Therapy. Clinical Development|March 25, 2017
Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck CancerClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Journal of Parkinson'S Disease|August 18, 2020
Gastric Motility in Parkinson's Disease is Altered Depending on the Digestive Phase and Does Not Correlate with Patient-Reported Motor FluctuationsLaura Ruck, Marcus M Unger, Jörg Spiegel, et al.
NPJ Parkinson'S Disease|December 10, 2019
Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiotaSeverin Weis, Andreas Schwiertz, Marcus M Unger, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill PatientsM G Vossen, D Knafl, M Haidinger, et al.
JNCI Cancer Spectrum|July 25, 2020
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJoseph M Unger, Dawn L Hershman, Raymond U Osarogiagbon, et al.
American Journal of Veterinary Research|July 25, 2017
Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of catsClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2013
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213S H Bernstein, E Epner, J M Unger, et al.
Pageof 61